Company Overview and News

1
Will Higher Premiums Aid Progressive's (PGR) Q3 Earnings?

2018-10-12 zacks
The Progressive Corporation (PGR - Free Report) is slated to report third-quarter 2018 results on Oct 16 before market open. The company has a solid track of delivering a positive surprise in each of the last four quarters. Factors to be Considered in Q3 Progressive is expected to have witnessed another quarter of sturdy policies in force across all its business lines, driving premiums higher. This coupled with improved investment income (attributable to sustained rate hikes) and higher service revenues and fees as well as other revenues should have fueled top-line improvement in the to be reported quarter.
CBSH TMK CBSHP RNR PGR MTG TMK CBCB

 
MGIC Investment (MTG) Q3 Earnings Preview: What to Watch Ahead of the Release

2018-10-10 zacks
The market expects MGIC Investment (MTG - Free Report) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2018. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
MTG

138
Top Analyst Reports for Home Depot, Bristol-Myers & Costco

2018-10-05 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Home Depot (HD), Bristol-Myers (BMY) and Costco (COST). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
AMP HD LMT RAD UTX MTG ECL

5
Should Value Investors Buy Target (TGT) Stock?

2018-10-01 zacks
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
TGT WBA FSLR MTG

3
Should Value Investors Buy United Continental (UAL) Stock?

2018-10-01 zacks
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
WBA FSLR MTG

3
Is PulteGroup (PHM) a Great Value Stock Right Now?

2018-10-01 zacks
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PHM WBA FSLR MTG

3
Is Energy Transfer Partners, L.P. (ETP) a Great Value Stock Right Now?

2018-10-01 zacks
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
ETP WBA FSLR MTG

6
Are Investors Undervaluing Changyou.Com (CYOU) Right Now?

2018-10-01 zacks
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CYOU WBA FSLR MTG

3
Is Quad/Graphics (QUAD) a Great Value Stock Right Now?

2018-10-01 zacks
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
WBA QUAD FSLR MTG

3
Why Chevron (CVX) is a Great Dividend Stock Right Now

2018-10-01 zacks
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
CVX WBA FSLR MTG

3
Are You Looking for a High-Growth Dividend Stock? Huntsman (HUN) Could Be a Great Choice

2018-10-01 zacks
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
HUN WBA FSLR MTG

3
Should Value Investors Buy Photronics (PLAB) Stock?

2018-10-01 zacks
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
PLAB WBA FSLR MTG

3
Why Telephone & Data Systems (TDS) is a Great Dividend Stock Right Now

2018-10-01 zacks
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
WBA FSLR MTG

3
Is TC PipeLines, LP (TCP) a Great Value Stock Right Now?

2018-10-01 zacks
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
TCP WBA FSLR MTG

3
Are Investors Undervaluing Covenant Transportation (CVTI) Right Now?

2018-10-01 zacks
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.
WBA FSLR MTG

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to MTG / MGIC Investment Corp. on message board site Silicon Investor.

Magnifoam Tech MTG/ASE Magnifoam Tech MTG/ASE Magnifoam Tech MTG/ASE MGIC Investment Corp. (NYSE:MTG) MGIC Investment Corp. (NYSE:MTG) MGIC Investment Corp. (NYSE:MTG)
Somatogen (SMTG) Somatogen (SMTG) Somatogen (SMTG) Somatogen / SMTG Somatogen / SMTG Somatogen / SMTG
CUSIP: 552848103